Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

Speaking in depth about her depression, Welch shared the tell-tale signs that occur in her body when a depressive episode is ...

Cybin pushes forward with Phase 3 depression trials after posting a narrower loss, while securing a $100M funding program.

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

The following is a summary of “Causal relationship between major depressive disorder, anxiety disorder and constipation: a ...

Axsome settles Auvelity patent litigation with Teva, delaying a generic launch until 2038. Analysts see growth potential with Symbravo's migraine approval.

With the settlement, Teva will not market the Auvelity generic until September 30, 2038, Axsome said in a Monday press ...

Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.

Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...

Do you know what bipolar disorder involves? Are you sure? Psychiatrist David Medina helps separates the myths from the facts.

Schizophrenia and major depressive disorder (MDD) may be genetically associated with increased risk for constipation but only the latter association appears to be clinically significant, according to ...